Phosphodiesterase Inhibitors in Vascular Ischemia: A Case Report and Review of Their Use in Ischemic Conditions

Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies

(2009) Vincenzo Mirone et al.   BJU INTERNATIONAL

Vision Disorders and Phosphodiesterase Type 5 Inhibitors

(2009) Alan M. Laties   DRUG SAFETY

Evaluation of the Effect of Sildenafil and Vascular Endothelium Growth Factor Combination Treatment on Skin Flap Survival in Rats

(2008) John W. Tsai et al.   AESTHETIC PLASTIC SURGERY

Does Sildenafil Cause Myocardial Infarction or Sudden Cardiac Death?

(2008) Konstantinos Kontaras et al.   American Journal of Cardiovascular Drugs

The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging

(2008) K. Domek-Łopacińska et al.   BRAIN RESEARCH

Sildenafil

(2008) Katherine F Croom et al.   DRUGS

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

(2008) Olga A. H. Reneerkens et al.   PSYCHOPHARMACOLOGY

Diagnosis and Management of Scleroderma Peripheral Vascular Disease

(2008) Ariane Herrick   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA